medigraphic.com

2017, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (S1)

Reintervention with percutaneous balloon angioplasty in patients with congenital heart disease with left-sided obstructions

Márquez-González H, López-Gallegos D, Pérez-Velázquez NA, Yáñez-Gutiérrez L

Language: Spanish
References: 17
Page: 86-91
PDF size: 272.60 Kb.


ABSTRACT

Background: Left-sided cardiac obstructions represent 15% of congenital heart disease (CHD). The treatment in adults is surgical; however, balloon dilation by interventional catheterization can alleviate the symptoms in pediatric patients to allow them to reach the target height. The aim was to determine the survival and the factors associated with reintervention in patients with CHD with left-sided obstruction treated with balloon angioplasty.
Methods: A cohort study was conducted in patients aged 4 to 17 years with left-sided heart obstruction (valvular stenosis [VS], supravalvular aortic stenosis [SAS], coarctation of the aorta [CA]) successfully treated with balloon angioplasty. The follow-up was of 10 years and the outcome variable was the restenosis with reintervention criteria. Pediatric stage at the time of the procedure, nutritional status, residual gradient, and presence of genetic syndromes were considered prognostic variables. For statistical analysis, measures of central tendency and dispersion were used. Chi squared was employed in qualitative variables and Kruskal-Wallis in quantitative variables.
Results: We had a total of 110 patients: 40% had CA, 35% VS, and 25% SAS. 39% required reintervention: 80% in SAS, 35% in CA, and 14% in VS.
Conclusion: The intervention balloon is a stopgap measure that allows patients with left-sided obstructions to reach the target height.


REFERENCES

  1. Narvencar KP, Jaques e Costa AK, Patil VR. Shone’s complex. J Assoc Phys India. 2009;57:415-6.

  2. Suojaranta-Ylinen RT, Soisalon-Soininen S, Kaartinen M, Maasilta PK, Vainikka TL, Vento AE, et al. Outcome of aortic valve replacement wirh bioprostheses in the ederly. J Heart Valve Dis. 2009 Sep;18(5):514-23.

  3. Victor S. Patch aortoplasty for coarctation of aorta: technical considerations.Ann Thorac Surg. 1995; 59:1276-8.

  4. Calderón-Colmenero J, Cervantes-Salazar JL, Curi- Curi PJ, Ramírez-Marroquín S. Problemática de las cardiopatías congénitas en México. Propuesta de regionalización. Arch Cardiol Mex. 2010;80(2): 133-40.

  5. Waterlow JC, Scrimshaw NS. The concept of Kwashiorkor from a public health point of view. Bull World Health Organ. 1957;16(2):458-64.

  6. Kuczmarski RJ, Ogden CL, Guo SS, Grummer- Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 11. 2002 May;(246):1-190.

  7. Holzer R, Qureshi S, Ghasemi A, Vincent J, Sievert H, Gruenstein D, et al. Stenting of aortic coarctation: acute, intermediate, and long-term results of a prospective multi-institutional registry--Congenital Cardiovascular Interventional Study Consortium (CCISC). Catheter Cardiovasc Interv. 2010 Oct 1;76(4):553-63. doi: 10.1002/ccd.22587.

  8. Gewlling M, Budts W, Boshoff D, Maleux G. Percutaneous interventions of the aorta. Future Cardio. 2002;8(2):251-69.

  9. Oh JK, Taliercio CP, Holmes DR Jr, Reeder GS, Bailey KR, Seward JB, et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol. 1988 Jun;11(6):1227-34.

  10. Eltchaninoff H, Durand E, Borz B, Furuta A, Bejar K, Canville A, et al. Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes. Am Heart J. 2014 Feb;167(2):235-40. doi: 10.1016/j.ahj.2013.10.019.

  11. Stamm C, Kreutzer C, Zurakowski D, Nollert G, Friehs I, Mayer JE, et al. Forty-one years of surgical experience with congenital supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 1999 Nov;118(5):874-85.

  12. Collins RT 2nd, Kaplan P, Somes GW, Rome JJ. Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr. 2010 Feb;156(2):253-8.e1. doi: 10.1016/j. jpeds.2009.08.042.

  13. Brown JW, Ruzmetov M, Vijay P, Turrentine MW. Surgical repair of congenital supravalvular aortic stenosis in children. Eur J Cardiothorac Surg. 2002 Jan;21(1):50-6.

  14. Pádua LM, Garcia LC, Rubira CJ, de Oliveira Carvalho PE. Stent placement versus surgery for coarctation of the thoracic aorta. Cochrane Database Syst Rev. 2012 May 16;(5):CD008204. doi: 10.1002/14651858. CD008204.pub2.

  15. Forbes TJ, Kim DW, Du W, Turner DR, Holzer R, Amin Z, et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol. 2011 Dec 13;58(25):2664-74. doi: 10.1016/j.jacc.2011.08.053.

  16. Mathieu P, Després JP, Pibarot P. The valvulometabolic risk in calcific aortic valve disease. Can J Cardiol.2007;23(Suppl B):32B-39B.

  17. Smith-Parrish M, Yu S, Rocchini A. Obesity and elevated blood pressure following repair of coartaction of the aorta. J Peaditr. 2014;164(5):1974-8.




2020     |     www.medigraphic.com